APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Based on Gene Therapy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Based on Gene Therapy Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchDrug Based on Gene Therapy Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Based on Gene Therapy Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Drug Based on Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Based on Gene Therapy Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Based on Gene Therapy Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Drug Based on Gene Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Based on Gene Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Based on Gene Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Based on Gene Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Based on Gene Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Based on Gene Therapy include Novartis, Biogen, Amgen, Sunway Biotech, Spark Therapeutics, SIBIONO, Sarepta Therapeutics, Orchard Therapeutics and Human Stem Cells Institute, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Based on Gene Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Based on Gene Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Based on Gene Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Based on Gene Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Based on Gene Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Based on Gene Therapy revenue, projected growth trends, production technology, application and end-user industry.

Drug Based on Gene Therapy Segment by Company

Novartis

Biogen

Amgen

Sunway Biotech

Spark Therapeutics

SIBIONO

Sarepta Therapeutics

Orchard Therapeutics

Human Stem Cells Institute

Gilead Sciences

bluebird bio

AnGes

Alnylam Pharmaceuticals

Akcea Therapeutics

Drug Based on Gene Therapy Segment by Type

Viral Gene Therapy

Non-viral Gene Therapy

Drug Based on Gene Therapy Segment by Application

Neurological Diseases

Cancer

Other

Drug Based on Gene Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Based on Gene Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Based on Gene Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Based on Gene Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Based on Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Based on Gene Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Based on Gene Therapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Based on Gene Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Viral Gene Therapy Major Player Table 3. Non-viral Gene Therapy Major Player Table 4. Global Drug Based on Gene Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Neurological Diseases Major Player Table 6. Cancer Major Player Table 7. Other Major Player Table 8. Drug Based on Gene Therapy Industry Trends Table 9. Drug Based on Gene Therapy Industry Drivers Table 10. Drug Based on Gene Therapy Industry Opportunities and Challenges Table 11. Drug Based on Gene Therapy Industry Restraints Table 12. Global Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Drug Based on Gene Therapy Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Drug Based on Gene Therapy Market Share by Region (2021-2026) Table 15. Global Drug Based on Gene Therapy Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Drug Based on Gene Therapy Market Share by Region (2027-2032) Table 17. Global Drug Based on Gene Therapy Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Drug Based on Gene Therapy Revenue Market Share by Players (2021-2026) Table 19. Global Drug Based on Gene Therapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Drug Based on Gene Therapy Key Players Headquarters & Area Served Table 21. Global Drug Based on Gene Therapy Players, Product Type & Application Table 22. Global Drug Based on Gene Therapy Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Drug Based on Gene Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Drug Based on Gene Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drug Based on Gene Therapy Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Drug Based on Gene Therapy Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Drug Based on Gene Therapy Revenue Market Share by Type (2021-2026) Table 29. Global Drug Based on Gene Therapy Revenue Market Share by Type (2027-2032) Table 30. Global Drug Based on Gene Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drug Based on Gene Therapy Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Drug Based on Gene Therapy Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Drug Based on Gene Therapy Revenue Market Share by Application (2021-2026) Table 34. Global Drug Based on Gene Therapy Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Drug Based on Gene Therapy Product Portfolio Table 39. Novartis Recent Development Table 40. Biogen Company Information Table 41. Biogen Business Overview Table 42. Biogen Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Biogen Drug Based on Gene Therapy Product Portfolio Table 44. Biogen Recent Development Table 45. Amgen Company Information Table 46. Amgen Business Overview Table 47. Amgen Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amgen Drug Based on Gene Therapy Product Portfolio Table 49. Amgen Recent Development Table 50. Sunway Biotech Company Information Table 51. Sunway Biotech Business Overview Table 52. Sunway Biotech Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sunway Biotech Drug Based on Gene Therapy Product Portfolio Table 54. Sunway Biotech Recent Development Table 55. Spark Therapeutics Company Information Table 56. Spark Therapeutics Business Overview Table 57. Spark Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Spark Therapeutics Drug Based on Gene Therapy Product Portfolio Table 59. Spark Therapeutics Recent Development Table 60. SIBIONO Company Information Table 61. SIBIONO Business Overview Table 62. SIBIONO Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. SIBIONO Drug Based on Gene Therapy Product Portfolio Table 64. SIBIONO Recent Development Table 65. Sarepta Therapeutics Company Information Table 66. Sarepta Therapeutics Business Overview Table 67. Sarepta Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sarepta Therapeutics Drug Based on Gene Therapy Product Portfolio Table 69. Sarepta Therapeutics Recent Development Table 70. Orchard Therapeutics Company Information Table 71. Orchard Therapeutics Business Overview Table 72. Orchard Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Orchard Therapeutics Drug Based on Gene Therapy Product Portfolio Table 74. Orchard Therapeutics Recent Development Table 75. Human Stem Cells Institute Company Information Table 76. Human Stem Cells Institute Business Overview Table 77. Human Stem Cells Institute Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Human Stem Cells Institute Drug Based on Gene Therapy Product Portfolio Table 79. Human Stem Cells Institute Recent Development Table 80. Gilead Sciences Company Information Table 81. Gilead Sciences Business Overview Table 82. Gilead Sciences Drug Based on Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Gilead Sciences Drug Based on Gene Therapy Product Portfolio Table 84. Gilead Sciences Recent Development Table 85. bluebird bio Company Information Table 86. bluebird bio Business Overview Table 87. bluebird bio Drug Based on Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. bluebird bio Drug Based on Gene Therapy Product Portfolio Table 89. bluebird bio Recent Development Table 90. AnGes Company Information Table 91. AnGes Business Overview Table 92. AnGes Drug Based on Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. AnGes Drug Based on Gene Therapy Product Portfolio Table 94. AnGes Recent Development Table 95. Alnylam Pharmaceuticals Company Information Table 96. Alnylam Pharmaceuticals Business Overview Table 97. Alnylam Pharmaceuticals Drug Based on Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Portfolio Table 99. Alnylam Pharmaceuticals Recent Development Table 100. Akcea Therapeutics Company Information Table 101. Akcea Therapeutics Business Overview Table 102. Akcea Therapeutics Drug Based on Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Akcea Therapeutics Drug Based on Gene Therapy Product Portfolio Table 104. Akcea Therapeutics Recent Development Table 105. North America Drug Based on Gene Therapy Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Drug Based on Gene Therapy Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Drug Based on Gene Therapy Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Drug Based on Gene Therapy Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Drug Based on Gene Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Drug Based on Gene Therapy Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Drug Based on Gene Therapy Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Drug Based on Gene Therapy Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Drug Based on Gene Therapy Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Drug Based on Gene Therapy Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Drug Based on Gene Therapy Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Drug Based on Gene Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Drug Based on Gene Therapy Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Drug Based on Gene Therapy Revenue by Country (US$ Million) & (2027-2032) Table 119. China Drug Based on Gene Therapy Revenue by Type (2021-2026) & (US$ Million) Table 120. China Drug Based on Gene Therapy Revenue by Type (2027-2032) & (US$ Million) Table 121. China Drug Based on Gene Therapy Revenue by Application (2021-2026) & (US$ Million) Table 122. China Drug Based on Gene Therapy Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Drug Based on Gene Therapy Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Drug Based on Gene Therapy Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Drug Based on Gene Therapy Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Drug Based on Gene Therapy Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Drug Based on Gene Therapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Drug Based on Gene Therapy Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Drug Based on Gene Therapy Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Drug Based on Gene Therapy Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Drug Based on Gene Therapy Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Drug Based on Gene Therapy Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Drug Based on Gene Therapy Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Drug Based on Gene Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Drug Based on Gene Therapy Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Drug Based on Gene Therapy Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Drug Based on Gene Therapy Image Figure 2. Global Drug Based on Gene Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Based on Gene Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Viral Gene Therapy Image Figure 5. Non-viral Gene Therapy Image Figure 6. Global Drug Based on Gene Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Drug Based on Gene Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 8. Neurological Diseases Image Figure 9. Cancer Image Figure 10. Other Image Figure 11. Global Drug Based on Gene Therapy Market Size (US$ Million) & (2021-2032) Figure 12. Global Drug Based on Gene Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Drug Based on Gene Therapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Drug Based on Gene Therapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Drug Based on Gene Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Drug Based on Gene Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Drug Based on Gene Therapy Revenue Market Share by Type (2021-2032) Figure 19. Global Drug Based on Gene Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drug Based on Gene Therapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Drug Based on Gene Therapy Revenue Market Share by Application (2021-2032) Figure 22. North America Drug Based on Gene Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Drug Based on Gene Therapy Revenue Share by Type (2021-2032) Figure 24. North America Drug Based on Gene Therapy Revenue Share by Application (2021-2032) Figure 25. North America Drug Based on Gene Therapy Revenue Share by Country (2021-2032) Figure 26. United States Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Drug Based on Gene Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Drug Based on Gene Therapy Revenue Share by Type (2021-2032) Figure 31. Europe Drug Based on Gene Therapy Revenue Share by Application (2021-2032) Figure 32. Europe Drug Based on Gene Therapy Revenue Share by Country (2021-2032) Figure 33. Germany Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Drug Based on Gene Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Drug Based on Gene Therapy Revenue Share by Type (2021-2032) Figure 43. China Drug Based on Gene Therapy Revenue Share by Application (2021-2032) Figure 44. Asia Drug Based on Gene Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Drug Based on Gene Therapy Revenue Share by Type (2021-2032) Figure 46. Asia Drug Based on Gene Therapy Revenue Share by Application (2021-2032) Figure 47. Asia Drug Based on Gene Therapy Revenue Share by Region (2021-2032) Figure 48. Japan Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Drug Based on Gene Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Drug Based on Gene Therapy Revenue Share by Type (2021-2032) Figure 56. SAMEA Drug Based on Gene Therapy Revenue Share by Application (2021-2032) Figure 57. SAMEA Drug Based on Gene Therapy Revenue Share by Country (2021-2032) Figure 58. Brazil Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Drug Based on Gene Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Therapy
  • Non-viral Gene Therapy
Applications
  • Neurological Diseases
  • Cancer
  • Other
Companies covered
  • Novartis
  • Biogen
  • Amgen
  • Sunway Biotech
  • Spark Therapeutics
  • SIBIONO
  • Sarepta Therapeutics
  • Orchard Therapeutics
  • Human Stem Cells Institute
  • Gilead Sciences
  • bluebird bio
  • AnGes
  • Alnylam Pharmaceuticals
  • Akcea Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Based on Gene Therapy Market by Type
  3. 1.2.1 Global Drug Based on Gene Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Viral Gene Therapy
  5. 1.2.3 Non-viral Gene Therapy
  6. 1.3 Drug Based on Gene Therapy Market by Application
  7. 1.3.1 Global Drug Based on Gene Therapy Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Neurological Diseases
  9. 1.3.3 Cancer
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Drug Based on Gene Therapy Market Dynamics
  1. 2.1 Drug Based on Gene Therapy Industry Trends
  2. 2.2 Drug Based on Gene Therapy Industry Drivers
  3. 2.3 Drug Based on Gene Therapy Industry Opportunities and Challenges
  4. 2.4 Drug Based on Gene Therapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Based on Gene Therapy Market Perspective (2021-2032)
  2. 3.2 Global Drug Based on Gene Therapy Growth Trends by Region
  3. 3.2.1 Global Drug Based on Gene Therapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Based on Gene Therapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Based on Gene Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Based on Gene Therapy Revenue by Players
  2. 4.1.1 Global Drug Based on Gene Therapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Based on Gene Therapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Based on Gene Therapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Based on Gene Therapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Based on Gene Therapy Key Players Headquarters & Area Served
  7. 4.4 Global Drug Based on Gene Therapy Players, Product Type & Application
  8. 4.5 Global Drug Based on Gene Therapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Based on Gene Therapy Market CR5 and HHI
  11. 4.6.3 2025 Drug Based on Gene Therapy Tier 1, Tier 2, and Tier 3
5 Drug Based on Gene Therapy Market Size by Type
  1. 5.1 Global Drug Based on Gene Therapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Based on Gene Therapy Revenue by Type (2021-2032)
  3. 5.3 Global Drug Based on Gene Therapy Revenue Market Share by Type (2021-2032)
6 Drug Based on Gene Therapy Market Size by Application
  1. 6.1 Global Drug Based on Gene Therapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Based on Gene Therapy Revenue by Application (2021-2032)
  3. 6.3 Global Drug Based on Gene Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Drug Based on Gene Therapy Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Biogen
  8. 7.2.1 Biogen Company Information
  9. 7.2.2 Biogen Business Overview
  10. 7.2.3 Biogen Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biogen Drug Based on Gene Therapy Product Portfolio
  12. 7.2.5 Biogen Recent Developments
  13. 7.3 Amgen
  14. 7.3.1 Amgen Company Information
  15. 7.3.2 Amgen Business Overview
  16. 7.3.3 Amgen Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Drug Based on Gene Therapy Product Portfolio
  18. 7.3.5 Amgen Recent Developments
  19. 7.4 Sunway Biotech
  20. 7.4.1 Sunway Biotech Company Information
  21. 7.4.2 Sunway Biotech Business Overview
  22. 7.4.3 Sunway Biotech Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sunway Biotech Drug Based on Gene Therapy Product Portfolio
  24. 7.4.5 Sunway Biotech Recent Developments
  25. 7.5 Spark Therapeutics
  26. 7.5.1 Spark Therapeutics Company Information
  27. 7.5.2 Spark Therapeutics Business Overview
  28. 7.5.3 Spark Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Spark Therapeutics Drug Based on Gene Therapy Product Portfolio
  30. 7.5.5 Spark Therapeutics Recent Developments
  31. 7.6 SIBIONO
  32. 7.6.1 SIBIONO Company Information
  33. 7.6.2 SIBIONO Business Overview
  34. 7.6.3 SIBIONO Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 SIBIONO Drug Based on Gene Therapy Product Portfolio
  36. 7.6.5 SIBIONO Recent Developments
  37. 7.7 Sarepta Therapeutics
  38. 7.7.1 Sarepta Therapeutics Company Information
  39. 7.7.2 Sarepta Therapeutics Business Overview
  40. 7.7.3 Sarepta Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sarepta Therapeutics Drug Based on Gene Therapy Product Portfolio
  42. 7.7.5 Sarepta Therapeutics Recent Developments
  43. 7.8 Orchard Therapeutics
  44. 7.8.1 Orchard Therapeutics Company Information
  45. 7.8.2 Orchard Therapeutics Business Overview
  46. 7.8.3 Orchard Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Orchard Therapeutics Drug Based on Gene Therapy Product Portfolio
  48. 7.8.5 Orchard Therapeutics Recent Developments
  49. 7.9 Human Stem Cells Institute
  50. 7.9.1 Human Stem Cells Institute Company Information
  51. 7.9.2 Human Stem Cells Institute Business Overview
  52. 7.9.3 Human Stem Cells Institute Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Human Stem Cells Institute Drug Based on Gene Therapy Product Portfolio
  54. 7.9.5 Human Stem Cells Institute Recent Developments
  55. 7.10 Gilead Sciences
  56. 7.10.1 Gilead Sciences Company Information
  57. 7.10.2 Gilead Sciences Business Overview
  58. 7.10.3 Gilead Sciences Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Gilead Sciences Drug Based on Gene Therapy Product Portfolio
  60. 7.10.5 Gilead Sciences Recent Developments
  61. 7.11 bluebird bio
  62. 7.11.1 bluebird bio Company Information
  63. 7.11.2 bluebird bio Business Overview
  64. 7.11.3 bluebird bio Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  65. 7.11.4 bluebird bio Drug Based on Gene Therapy Product Portfolio
  66. 7.11.5 bluebird bio Recent Developments
  67. 7.12 AnGes
  68. 7.12.1 AnGes Company Information
  69. 7.12.2 AnGes Business Overview
  70. 7.12.3 AnGes Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  71. 7.12.4 AnGes Drug Based on Gene Therapy Product Portfolio
  72. 7.12.5 AnGes Recent Developments
  73. 7.13 Alnylam Pharmaceuticals
  74. 7.13.1 Alnylam Pharmaceuticals Company Information
  75. 7.13.2 Alnylam Pharmaceuticals Business Overview
  76. 7.13.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Portfolio
  78. 7.13.5 Alnylam Pharmaceuticals Recent Developments
  79. 7.14 Akcea Therapeutics
  80. 7.14.1 Akcea Therapeutics Company Information
  81. 7.14.2 Akcea Therapeutics Business Overview
  82. 7.14.3 Akcea Therapeutics Drug Based on Gene Therapy Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Akcea Therapeutics Drug Based on Gene Therapy Product Portfolio
  84. 7.14.5 Akcea Therapeutics Recent Developments
8 North America
  1. 8.1 North America Drug Based on Gene Therapy Revenue (2021-2032)
  2. 8.2 North America Drug Based on Gene Therapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Based on Gene Therapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Based on Gene Therapy Revenue by Type (2027-2032)
  5. 8.3 North America Drug Based on Gene Therapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Based on Gene Therapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Based on Gene Therapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Based on Gene Therapy Revenue by Application (2027-2032)
  9. 8.5 North America Drug Based on Gene Therapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Based on Gene Therapy Revenue by Country
  11. 8.6.1 North America Drug Based on Gene Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Based on Gene Therapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Based on Gene Therapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Drug Based on Gene Therapy Revenue (2021-2032)
  2. 9.2 Europe Drug Based on Gene Therapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Based on Gene Therapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Based on Gene Therapy Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Based on Gene Therapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Based on Gene Therapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Based on Gene Therapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Based on Gene Therapy Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Based on Gene Therapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Based on Gene Therapy Revenue by Country
  11. 9.6.1 Europe Drug Based on Gene Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Based on Gene Therapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Based on Gene Therapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Drug Based on Gene Therapy Revenue (2021-2032)
  2. 10.2 China Drug Based on Gene Therapy Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Based on Gene Therapy Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Based on Gene Therapy Revenue by Type (2027-2032)
  5. 10.3 China Drug Based on Gene Therapy Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Based on Gene Therapy Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Based on Gene Therapy Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Based on Gene Therapy Revenue by Application (2027-2032)
  9. 10.5 China Drug Based on Gene Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Based on Gene Therapy Revenue (2021-2032)
  2. 11.2 Asia Drug Based on Gene Therapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Based on Gene Therapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Based on Gene Therapy Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Based on Gene Therapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Based on Gene Therapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Based on Gene Therapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Based on Gene Therapy Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Based on Gene Therapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Based on Gene Therapy Revenue by Country
  11. 11.6.1 Asia Drug Based on Gene Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Based on Gene Therapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Based on Gene Therapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Based on Gene Therapy Revenue (2021-2032)
  2. 12.2 SAMEA Drug Based on Gene Therapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Based on Gene Therapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Based on Gene Therapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Based on Gene Therapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Based on Gene Therapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Based on Gene Therapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Based on Gene Therapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Based on Gene Therapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Based on Gene Therapy Revenue by Country
  11. 12.6.1 SAMEA Drug Based on Gene Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Based on Gene Therapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Based on Gene Therapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst